2McCullough PA,Philbin EF,Spertus JA,et al.Confirmation of a heart failure episemic:findings from the resource utilization among congestive heart failure(R E A C H)Study[J].J Am Coll Cardiol,200,39:60
3Dibbs Z,Thornby J,White BG,et al.Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure:implications for clinical trials[J].J Am Coll Cardiol,1999,33:1935
4Dao Q,Krishnaswarny P,Kazanegra R,et al.Utility of B-type natri-uretic peptide(BNP)in the diagnosis of CHF in an urgent care setting [J].J Am Coll Cardiol,2001,37:379
6Troughton RW,Frampton CM,Yandle TG,et al.Treatment of heart failure guided by plasma aminoterminal brain natriuetic peptide(N-BNP)concentrations[J].Lancet,2000,355:1126
7Colucci WS. Molecular and cellular mechanisms of myocardial failure. Am J Cardiol, 1997, 80(11A) : 15L-25L
8Braunwald E,Bristow MR Congestive heart failure: fifty years of progress. Circulation, 2000, 102(20 Suppl 4) : Ⅳ14-23.
9Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the 2001 Guidelines for the Evaluation and Management of Heart Failure) : developed in collaboration with the American College of Chest Physicians and the International Society for Heart and Lung Transplantation: endorsed by the Heart Rhythm Society. Circulation, 2005, 112 (12) :e154-235.
10Swedberg K, Cleland J, Dargie H, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary ( update 2005 ):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J, 2005, 26(11): 1115-1140.
